Search
News Chat
Login
Search
Top
For You
Business
Crypto
Culture
Environment
Politics
Science
Sports
Tech
Video Games
World
Tirzepatide News
Prediction markets for Tirzepatide
Prediction markets for Tirzepatide
ITP: Which drug(s) will increase median lifespan the most in males by 2030?
Dec 17, 8:58 AM
Jan 1, 11:59 PM
5
138
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
Jul 2, 7:40 AM
Jan 1, 4:59 AM
32.98%
chance
20
684
Option
Votes
YES
NO
1154
903
More than 10% of US citizens will be on prescription drugs for weight loss by 2031
Jan 5, 1:06 AM
Jun 1, 7:00 PM
57.47%
chance
42
1389
Option
Votes
YES
NO
1099
807
More than 30% of US citizens will be on prescription drugs for weight loss by 2031
Jan 5, 1:07 AM
Jun 1, 7:00 PM
19.37%
chance
33
1272
Option
Votes
YES
NO
1257
912
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
Mar 8, 4:50 PM
Dec 31, 10:59 PM
30.27%
chance
24
1255
Option
Votes
YES
NO
1185
849
Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by 01/01/2025?
Dec 28, 8:31 PM
Jan 1, 11:59 PM
14.83%
chance
12
697
Option
Votes
YES
NO
1179
940
Will Eli Lilly's new weight loss drug Zepbound sell >$2B in the US by 2025? (first full year on the market)
Nov 13, 5:34 AM
Feb 16, 4:59 AM
72.12%
chance
4
80
Option
Votes
NO
YES
153
85
Articles
Latest stories
Clinical Trials Show Tirzepatide Benefits with Significant Improvements in Airway Blockage Events and Weight Loss, Link to Depression and Poor Health
Authors
6
2 months
Politics
Eli Lilly's Wegovy Maker Inks $16.5B Deal, Reports Tirzepatide's Success in Q4 Earnings Beat; Amgen Expects 20% Revenue Jump in 2024
Authors
34
5 months
Economics
Business
Amgen's MariTide Shows Promise, Eli Lilly's Tirzepatide Reduces Blood Pressure; Chegg, UBS, BP Report Q4 Earnings
Authors
39
5 months
Economics
Business
Previous
Next
